Cancer

Items 131-138 of 138

Page
per page
Set Descending Direction
  1. Tivozanib
    CAS  475108-18-0
    SYN-1013
    SYN-1013-M0011 mg
    CHF 114.00
    SYN-1013-M0055 mg
    CHF 184.00
    SYN-1013-M01010 mg
    CHF 263.00
    SYN-1013-M05050 mg
    CHF 858.00
    SYN-1013-M100100 mgINQ
    Tivozanib
  2. Tozasertib
    CAS  639089-54-6
    SYN-1092
    SYN-1092-M0011 mg
    CHF 71.00
    SYN-1092-M0055 mg
    CHF 92.00
    SYN-1092-M01010 mg
    CHF 106.00
    SYN-1092-M05050 mg
    CHF 312.00
    SYN-1092-M100100 mg
    CHF 497.00
    Tozasertib
  3. URMC-099
    CAS  1229582-33-5
    SYN-1211
    SYN-1211-M0011 mg
    CHF 142.00
    SYN-1211-M0055 mg
    CHF 255.00
    SYN-1211-M01010 mg
    CHF 397.00
    SYN-1211-M05050 mg
    CHF 1'348.00
    SYN-1211-M100100 mgINQ
    URMC-099
  4. Vandetanib
    CAS  443913-73-3
    SYN-1090
    SYN-1090-M0011 mg
    CHF 85.00
    SYN-1090-M0055 mg
    CHF 114.00
    SYN-1090-M01010 mg
    CHF 142.00
    SYN-1090-M05050 mg
    CHF 355.00
    SYN-1090-M100100 mg
    CHF 553.00
    Vandetanib
  5. Vorinostat
    CAS  149647-78-9
    SYN-3006
    SYN-3006-M0055 mg
    CHF 57.00
    SYN-3006-M01010 mg
    CHF 71.00
    SYN-3006-M05050 mg
    CHF 99.00
    SYN-3006-M100100 mg
    CHF 128.00
    Vorinostat
  6. VTX-27
    CAS  1321924-70-2
    SYN-1206
    SYN-1206-M0011 mg
    CHF 312.00
    SYN-1206-M0055 mg
    CHF 837.00
    SYN-1206-M01010 mg
    CHF 1'348.00
    SYN-1206-M05050 mgINQ
    SYN-1206-M100100 mgINQ
    VTX-27
  7. XD14
    CAS  1370888-71-3
    SYN-3048
    SYN-3048-M0011 mg
    CHF 99.00
    SYN-3048-M0055 mg
    CHF 170.00
    SYN-3048-M01010 mg
    CHF 284.00
    SYN-3048-M05050 mg
    CHF 922.00
    SYN-3048-M100100 mgINQ
    XD14
  8. XL019
    CAS  945750-13-0
    SYN-1191
    SYN-1191-M0011 mg
    CHF 270.00
    SYN-1191-M0055 mg
    CHF 412.00
    SYN-1191-M01010 mg
    CHF 702.00
    SYN-1191-M05050 mgINQ
    SYN-1191-M100100 mgINQ
    XL019

Items 131-138 of 138

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.